Top 50 VC Funds & Investors in Belgium (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
PMV
VC Fund
|
89 | Belgium, United States, The Netherlands | Series A, Seed | Software, Biotechnology, Health Care | $549k–$40M |
|
Limburgse Reconversie Maatschappij
VC Fund
|
48 | Belgium, United States, The Netherlands | Seed, Series A | Information Technology, Software, Biotechnology | $494k–$11M |
|
S.R.I.W.
VC Fund
|
36 | Belgium, United States, Spain | Series A, Series B | Health Care, Biotechnology, Manufacturing | $411k–$75M |
|
Volta Ventures
VC Fund
|
35 | Belgium, The Netherlands, Luxembourg | Seed, Series A | Software, Information Technology, Artificial Intelligence | $549k–$8.8M |
|
Meusinvest (Noshaq)
VC Fund
|
35 | Belgium, France, Germany | Series A, Seed | Biotechnology, Health Care, Medical | $137k–$16M |
|
Qbic Fund
VC Fund
|
35 | Belgium, The Netherlands | Seed, Series A | Biotechnology, Software, Health Care | $868k–$47M |
|
Pitchdrive
VC Fund
|
32 | Belgium, United Kingdom, Spain | Pre-Seed, Seed, Series A | Software, SaaS, Artificial Intelligence | $110k–$4.6M |
|
WING by Digital Wallonia
VC Fund
|
30 | Belgium | Seed, Convertible Note, Series A | Software, Health Care, SaaS | $219k–$11M |
|
Gemma Frisius Fund
VC Fund
|
24 | Belgium, France, United Kingdom | Seed, Series B, Series A | Biotechnology, Health Care, Medical | $384k–$84M |
|
Sambrinvest
VC Fund
|
22 | Belgium, France, Spain | Seed, Series A, Series B | Biotechnology, Health Care, Medical | $411k–$57M |
|
Seeder Fund
VC Fund
|
22 | Belgium, Luxembourg, France | Seed, Pre-Seed, Series A | Software, Information Technology, SaaS | $219k–$8M |
|
Inventures SA
VC Fund
|
21 | Belgium, France, United Kingdom | Series A, Seed | Health Care, Biotechnology, Manufacturing | $82k–$13M |
|
Capricorn Partners
VC Fund
|
21 | Belgium, United States, The Netherlands | Series A, Series B | Biotechnology, Health Care, Software | $3.3M–$42M |
|
Fortino Capital
VC Fund
|
20 | Belgium, The Netherlands, Germany | Series A, Seed | Software, Information Technology, SaaS | $1.6M–$17M |
|
Gimv
VC Fund
|
19 | Belgium, United States, France | Series B, Series A | Biotechnology, Health Care, Medical | $3.3M–$69M |
|
LeanSquare
VC Fund
|
18 | Belgium, France, United States | Seed, Series A | Software, Music, Information Technology | $200k–$12M |
|
SmartFin
VC Fund
|
18 | Belgium, The Netherlands, Turkey | Series B, Series A | Software, SaaS, Information Technology | $3M–$30M |
|
Syndicate One
VC Fund
|
17 | Belgium, United Kingdom, United States | Pre-Seed, Seed, Series A | Artificial Intelligence, Software, SaaS | $1M–$13M |
|
V-Bio Ventures
VC Fund
|
16 | Belgium, France, United States | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $3.2M–$88M |
|
KBC
VC Fund
|
16 | Belgium, United States, France | Seed, Series A, Series B | Biotechnology, Health Care, FinTech | $549k–$65M |
|
The Faktory Fund
VC Fund
|
15 | Belgium, France, United States | Seed, Pre-Seed | Software, Analytics, Information Technology | $1.1M–$4.4M |
|
Be Angels
VC Fund
|
14 | Belgium, France, Spain | Seed, Pre-Seed | SaaS, Software, Health Care | $78k–$1.5M |
|
imec.xpand
VC Fund
|
14 | Belgium, United States, Germany | Seed, Series A, Series B | Semiconductor, Manufacturing, Medical Device | $3.3M–$100M |
|
Vives Louvain Technology Fund
VC Fund
|
13 | Belgium, France, United States | Series A, Series B | Health Care, Biotechnology, Medical | $491k–$125M |
|
Innovation Fund
VC Fund
|
13 | Belgium, France, Luxembourg | Seed, Series A | Health Care, Manufacturing, Information Technology | $329k–$5.8M |
|
Ark Angels Activator Fund
VC Fund
|
13 | Belgium | Series A, Seed | Software, Information Technology, SaaS | $932k–$7.4M |
|
Finance.Brussels
VC Fund
|
12 | Belgium, France | Seed, Series A | Software, Information Technology, Internet | $1.5M–$5.5M |
|
VIB
VC Fund
|
12 | Belgium, Brazil, Denmark | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $3.2M–$84M |
|
Flanders Innovation and Entrepreneurship (VLAIO)
VC Fund
|
11 | Belgium, Israel, Germany | Grant, Pre-Seed, Seed | Biotechnology, Health Care, Software | $200k–$3.2M |
|
Angelwise
VC Fund
|
11 | Belgium, The Netherlands | Seed, Pre-Seed | Software, SaaS, Information Technology | $521k–$3M |
|
Belfius Bank
VC Fund
|
10 | Belgium, France, The Netherlands | Debt Financing, Seed, Pre-Seed | Software, SaaS, Pharmaceutical | $291k–$382M |
|
Spreds
VC Fund
|
10 | Belgium, France | Series A, Seed, Series B | E-Commerce, Health Care, Online Portals | $165k–$2.5M |
|
XAnge
VC Fund
|
9 | France, Germany, Belgium | Series A, Seed, Series B | Software, SaaS, E-Commerce | $1.1M–$60M |
|
Newion
VC Fund
|
9 | The Netherlands, Belgium, Germany | Series A, Seed | Software, SaaS, Information Technology | $796k–$7.4M |
|
The CoFoundry
VC Fund
|
9 | Belgium, The Netherlands, United States | Seed, Series A | Software, SaaS, Security | $878k–$3.9M |
|
Lean FUND
VC Fund
|
8 | Belgium, United States, France | Seed, Series B | Internet, Apps, Software | $66k–$384k |
|
Newton Biocapital
VC Fund
|
8 | Belgium, Japan, France | Series A, Seed | Biotechnology, Medical, Pharmaceutical | $2.7M–$84M |
|
Peak
VC Fund
|
8 | The Netherlands, Germany, Sweden | Seed, Pre-Seed | Software, SaaS, Information Technology | $549k–$5M |
|
Vesalius Biocapital Partners
VC Fund
|
7 | Belgium, Germany, France | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $3.8M–$100M |
|
Big Bang Ventures
VC Fund
|
7 | Belgium, The Netherlands, United States | Series A, Series B | Software, Cloud Computing, Apps | $1M–$9M |
|
TCD Capital (ex TheClubDeal)
VC Fund
|
7 | Belgium, France | Series A, Series B, Seed | Health Care, Biotechnology, Information Technology | $2.2M–$18M |
|
E-Merge
VC Fund
|
7 | United States, Belgium, Spain | Seed, Series A | Software, SaaS, E-Commerce | $213k–$25M |
|
ING Group
VC Fund
|
7 | United Kingdom, United States, The Netherlands | Debt Financing, Post-IPO Debt | Energy, Renewable Energy, Solar | $75M–$3B |
|
Theodorus III
VC Fund
|
7 | Belgium, Canada, France | Seed, Series A | Health Care, Life Science, Medical | $2.2M–$11M |
|
SFPIM
VC Fund
|
7 | Belgium, France | Series A, Series B, Series C | Biotechnology, AgTech, Agriculture | $8.8M–$110M |
|
Finindus
VC Fund
|
7 | Belgium, United States, Sweden | Series A, Seed | Manufacturing, Industrial, Renewable Energy | $1.3M–$18M |
|
Entourage
VC Fund
|
6 | Belgium | Seed | B2B, Analytics | |
|
Spinventure
VC Fund
|
6 | Belgium | Series A | Health Care, Biotechnology, Medical | |
|
Saffelberg Investments
VC Fund
|
6 | Belgium | Series A, Seed | Software, Fashion, E-Commerce | $2.7M–$4.4M |
|
EQT Life Sciences
VC Fund
|
6 | United States, The Netherlands, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.9M–$140M |
| Access all 986 VC funds in Belgium startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Do and dare company
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Series A, Seed
- Geography: Belgium, United States, The Netherlands
Investor stats
- Total investments: 137
- Round size: Seed $549k–$3.8M; Series A $2.7M–$40M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Sweepatic — A user-friendly external attack surface management platform that automates the discovery and security analysis of your online attack surface.
- Minze Health — Digital Urology Starts Here from symptom to solution Home-based digital diagnostics and therapeutics for Male LUTS/BPH and OAB. Shaping the future of urology through meaningful data. Get In Touch Our Mission We're redefining how Male LUTS/BPH and OAB are diagnosed and treated Today's Challenge Lower urinary tract symptoms (LUTS) affect a growing group of patients.
- Predikt — Predikt empowers finance leaders to navigate today’s volatile markets with clarity and confidence. By integrating advanced AI, external market data, and internal financial metrics, Predikt transforms forecasting into a strategic advantage.Our pioneering Confidence Intelligence platform:- Provides transparency and automation to reduceforecasting uncertainty. - Enables CFOs to assess risks, identify opportunities, and align teams globally. - Turns data into decisions that foster resilience and drive growth.We understand the challenges finance leaders face: juggling a high-level view with local market complexities. That’s why Predikt is designed to enhance collaboration, challenge assumptions, and provide confidence in every number.Founded by a Swiss-Belgian team in 2023, Predikt is democratizing predictive technology, equipping finance teams to make smarter decisions and thrive amid uncertainty.
Oxygen for growth - LRM
Show more...Investment focus
- Industry: Information Technology, Software, Biotechnology
- Stage:Seed, Series A
- Geography: Belgium, United States, The Netherlands
Investor stats
- Total investments: 86
- Round size: Seed $494k–$5.2M; Series A $1.6M–$11M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- ADLC — ADLC employs drone technology to deliver logistics services, allowing businesses to implement drone-based solutions without having to manage them in-house. The company is focused on enhancing last-mile delivery in maritime and offshore environments. ADLC now conducts drone delivery services in the Port of Antwerp in collaboration with SGS, atesting and certification company, and works with companies such as BASF. Its drones have reduced delivery times and environmental effect, boosting efficiency sixfold and lowering CO2 emissions by up to 80% for petrochemical sample deliveries.
- MobieTrain — Train, connect and empower your frontline teams in minutes. MobieTrain boosts onboarding, training, engagement, and performance. All in one simple platform
- TrendMiner — TrendMinder designs and delivers a fast, powerful and intuitive industrial analytics platform for everyone in operations to make smarter, data-driven decisions.
The S.R.I.W. Group is an institution at the heart of the financial market that assists entrepreneurs in creating and developing businesses in the Walloon region. It reflects the effort of Wallonian industry in facing the challenges of the creation of economic value in the 21st century. Since its creation in 1979, the Société Régionaled’Investissement de Wallonie has continuously been expanding its abilities to adapt and anticipate as well as its flexibility in order to meet the requirements of its partners who are confronted with the evolution of the world economy. The principles of good governance, a strong business culture and shared values at the heart of the Group constitute important assets to capture the changing realities of the market and progress in a sustainable development perspective.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Series A, Series B
- Geography: Belgium, United States, Spain
Investor stats
- Total investments: 111
- Round size: Series A $411k–$31M; Series B $1.6M–$75M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Intressa Vascular — Intressa Vascular provides innovative solutions to address life-threatening cardiovascular conditions such as aortic dissection.
- Minoryx Therapeutics — Minoryx is focused on the discovery and development of novel treatments for severe, orphan diseases of the central nervous system with high unmet medical need.
- Santero Therapeutics — This is the homepage of the website
Volta Ventures is a venture capital firm that offers seed & early stage VC for internet & software companies in the Benelux.The fund’s team, with active support from some 30 business angels, expects to make a substantial impact on every company it invests in by working with the founders and management to identify new markets andcustomers, hire senior talent, provide ongoing guidance and arrange further financing rounds.Volta Ventures has offices in Ghent and Amsterdam.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Belgium, The Netherlands, Luxembourg
Investor stats
- Total investments: 85
- Round size: Seed $549k–$5.2M; Series A $2.2M–$8.8M
- Lead/follow: 52% lead, 48% follow
- Last fund: May invest from a new fund soon — raised $72M in 2019
Portfolio highlights
- Churned — Churned is a AI-driven customer success and retention software that reduces churn and boost CLV for SaaS, B2C-subscriptions and e-commerce.
- Alicia Insurance — Offer insurance, embedded into your brand. Live within a day. Learn all about our Insurance as a Service.
- Fero — Fero uses predictive AI to customize the payment process and pathway uniquely for every individual customer. Acknowledging the uniqueness of each customer and personalizing their checkout experience on an individual basis leads to an enhanced customer experience and, consequently, higher conversion rates. FERO's AI engine empowers itsclientsto strategically determine when to offer pricier payment methods and when to provide more economical choices, effectively lowering payment expenses while preserving conversion rates.
Noshaq offers financial services to help businesses develop.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed
- Geography: Belgium, France, Germany
Investor stats
- Total investments: 76
- Round size: Seed $137k–$6M; Series A $3.3M–$16M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- TrustUp — TrustUp is the home contractors platform, connects homeowners with verified quality home improvement.
- Le Fourgon — Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
The Qbic Fund is a multi-sector fund supporting spin-off companies of the Ghent, Brussels and Antwerp university associations and of VITO. Through its strategic partnership with the universities of Ghent, Brussels and Antwerp, and VITO, the Qbic Fund has early and privileged access to promising research projects at these partner universities. Ourinvestment approach is based on early in-depth and independent review and analysis followed by hands on involvement and support.In May 2012 the Qbic Fund held its first close and currently it has over € 30 million under management. The Qbic Fund is backed by several public and private investors and managed by Qbic Venture Partners.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Seed, Series A
- Geography: Belgium, The Netherlands
Investor stats
- Total investments: 50
- Round size: Seed $1.1M–$7.7M; Series A $868k–$47M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — raised $57M in 2022
Portfolio highlights
- Aloxy — Aloxy offers reliable IIot solutions tailored to the needs of the process industry. Our valve sensor provides an open and close indication of manual valves.
- Accelleran — Accelleran is pioneering a disruptive approach to the delivery of cost-effective, carrier and mission-critical grade TDD and FDD Small Cell networks through its focus on software quality and partnerships with volume manufacturers.Accelleran provides LTE Small Cell software and LTE Small Cell product solutions which address the real-worldchallenges of volume deployment of Small Cells. We offer turnkey solutions and unique experience on the challenges of integrating cellular technology on low cost, yet powerful platforms and architectures. Accelleran offers its customers solid and dependable system solutions, backed by the support of our unparalleled expertise.Accelleran’s technology is genuinely independent from any HW platform and enables operators to invest once in the integration and validation of a common software base that can be deployed across different segments, platforms and Small Cell architectural approaches to enable a truly integrated HetNet.
- Morrow Optics — Looking for the next big thing in eyewear technology? Check out Morrow's electrified progressives, also known as autofocals! These innovative glasses switch focus length with a touch of button, providing you with seamless vision from near to far. Learn more about this technology on Morrow's website.
Pitchdrive is a pre-seed investor run by experienced tech entrepreneurs backing founders during their crazy startup ride. Buckle up.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Pre-Seed, Seed, Series A
- Geography: Belgium, United Kingdom, Spain
Investor stats
- Total investments: 74
- Round size: Seed $500k–$4.6M; Pre-Seed $110k–$2M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Lette AI — Operating system built for modern property teams. Automate the work that holds portfolios back and unlock NOI growth.
- NineID — NineID provides a biometric access control solution and identity visitor management system that increases businesses' security, compliance, and safety.
- Openface — Digital skin diagnostic and personalized skincare
W.IN.G by Digital Wallonia invests in SAAS, advanced tech and deep tech startups (AI, drones, medtech, IOT,...). W.IN.G brings smart money by helping startups by bi-weekly interactions and providing an operating teams (seasonal entrepreneurs being hands-on with the portfolio).
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Convertible Note, Series A
- Geography: Belgium
Investor stats
- Total investments: 34
- Round size: Seed $346k–$1.9M; Series A $1.1M–$11M; Convertible Note $219k–$568k
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- IONNYK — IONNYK is a new medium of art photography, containing millions of tiny ink capsules.
- MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.
- Soil Capital Belgium — Discover Europe's first certified, multi-national carbon farming programme that rewards regenerative agriculture.
Gemma Frisius Fund KU Leuven is a seed capital fund that aims to stimulate the creation and growth of university related spin-off companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series B, Series A
- Geography: Belgium, France, United Kingdom
Investor stats
- Total investments: 34
- Round size: Seed $384k–$33M; Series A $932k–$84M; Series B $4.4M–$24M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Magics Technologies — Magics Technologies is a nuclear research center that develops autonomous machines for sustainable energy sources.
- Tavira Therapeutics — Tavira Therapeutics develops an innovative technology that equips AAV vectors with molecules to accurately target the intended tissues.
- Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
Sambrinvest is an active venture capital player in the region of Charleroi - Thuin.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Series B
- Geography: Belgium, France, Spain
Investor stats
- Total investments: 39
- Round size: Seed $544k–$24M; Series A $411k–$57M; Series B $4.4M–$44M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
- Vertical Compute — Vertical Compute offers chiplet-based technology that cuts data movement to achieve up to 80% energy savings.
- Enodia Therapeutics — Enodia Therapeutics pioneers targeted protein degradation at the Sec61 translocon, developing small-molecule therapies for inflammatory and autoimmune diseases.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Seeder Fund is an early-stage financing and growth capital for digital startups. For young start-ups with a start in commercial traction it offers seed funding of up to EUR 200,000 to validate their value proposition and product-market fit. For start-ups preparing for Series A it provides funding of up to EUR 300,000 to confirm the growth potentialand move closer to break-even. For scale-ups, the Seeder Fund can also help finance the company's growth, this time in the form of a capital stake of up to 1,000,000 EUR.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Belgium, Luxembourg, France
Investor stats
- Total investments: 32
- Round size: Seed $384k–$2.5M; Pre-Seed $219k–$2.4M; Series A $3.3M–$8M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- CrypDefi — Unified custody and compliance for institutional digital finance.
- Alice — Reimagining the legal drafting process with AI, allowing lawyers to concentrate on strategic decisions and achieve better legal outcomes.
- Vectrix — Vectrix offers AI-based automation and consulting solutions for businesses and logistics companies to automate workflows.
Inventures is a European venture capital fund that builds a better world through a portfolio of investments in sustainable businesses.The firm has two funds: Inventures I & Inventures II.Inventures was created to support early stage smart and innovative European businesses, to support sustainable job growth and empower entrepreneurs.Inventures empowers citizenship co-investments through a crowdfunding platform, MyMicroInvest.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Series A, Seed
- Geography: Belgium, France, United Kingdom
Investor stats
- Total investments: 46
- Round size: Seed $82k–$2.2M; Series A $411k–$13M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
- myskillcamp — Myskillcamp is a digital learning platform and educational design support service. Myskillcamp supports their customers in the digital transformation of their company and the launch of their Digital Learning project. From the audit of needs to the design of engaging educational devices, through a pilot phase, they make a point of honor to adapt thedigital to the specificities of each and give it meaning.With their online platform, businesses can manage their learner communities and connect all their partners in one place. Their tool also allows businesses to structure training spaces by skills, trades, brands within camps. In parallel, businesses can create educational content from scratch, select a map in their marketplace, or plan sessions in-class. Businesses can organize the distribution of their training to a single learner or to a whole group.
- Octave — A sustainable, cost-effective and reliable energy storage system with second-life batteries from electric vehicles.
Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B
- Geography: Belgium, United States, The Netherlands
Investor stats
- Total investments: 112
- Round size: Series A $3.3M–$18M; Series B $5.3M–$42M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Neotiv — Enabling cognitive health
- Thryve — Thryve’s SDK brings everything you need to access fragmented wearable, medical devices, and health data silos with a single integration. We unify your users’ data from smartwatches, blood glucose meters, and many other sources that unlock a continuous stream of harmonized health information for your care. We support popular data sources like AppleHealth, Google Fit, Huawei Health, Samsung Health, and many more.
- VOID Technologies — VOID Technologies is a groundbreaking materials science company spun out of Kimberly-Clark to commercialise the VO+ technology. Our business model is based on supplying VO+ additive masterbatches to film manufacturers.
We partner with exceptional B2B Software entrepreneurs across Northwestern Europe.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Series A, Seed
- Geography: Belgium, The Netherlands, Germany
Investor stats
- Total investments: 66
- Round size: Seed $1.6M–$6.7M; Series A $3M–$17M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Vaultspeed — Save your teams months of headache with a no-code approach to automate your multi-source data integration, Data Vault modeling & ETL/DDL code generation.
- Mobilexpense — Expense management solutions for mid-sized organisations and large enterprises. Automate your expense management: improve productivity and save costs.
- Getvisibility — Attain swift and comprehensive visibility and context for all your data, whether in motion or at rest, encompassing both on-premises and cloud environments. This empowers your teams to take proactive measures in identifying, prioritising, assigning ownership, remediating, and preventing risks that could impact your business, ensuring the utmost security across all aspects of your operations.
Gimv, a trusted European investment company, helps mid-market businesses create sustainable value through growth capital and expertise across diverse sectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: Belgium, United States, France
Investor stats
- Total investments: 162
- Round size: Series A $3.3M–$65M; Series B $7M–$69M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $622M in 2010
Portfolio highlights
- Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.
- ImCheck Therapeutics — ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.
- ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
New Economy Startups Investor & Accelerator
Show more...Investment focus
- Industry: Software, Music, Information Technology
- Stage:Seed, Series A
- Geography: Belgium, France, United States
Investor stats
- Total investments: 44
- Round size: Seed $200k–$2.5M; Series A $247k–$12M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- neuroClues — An easy-to-use eye-tracking environment to help practitioners instantaneously quantify their clinical exam
- Gamevestor — Be more than a player. Invest in expert-selected video game projects and earn a share of their commercial revenues.
- ClimateCamp — Looking for a sustainable way to collaborate with your suppliers on emissions reduction projects? Look no further than our platform - Book a demo for free!
Venture capital fund focussing on European B2B technology companies.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Series B, Series A
- Geography: Belgium, The Netherlands, Turkey
Investor stats
- Total investments: 50
- Round size: Series A $3.2M–$12M; Series B $3M–$30M
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — raised $281M in 2020
Portfolio highlights
- Locatee — Locatee is the leading workplace analytics solution that transforms complex data into space utilisation insight. Developed with a strong focus and a deep understanding of the corporate real estate challenges facing the modern world of work, Locatee empowers leaders and managers to make decisions about their business buildings with confidence.Locatee works by leveraging office occupancy data from multiple sources, processing them using unique patented technology, and beautifully visualising them all in one place. With workplace intelligence at fingertips’ length, it’s easy to identify optimisation potential, realise savings, and enhance company’s workplace experience across the entire real estate portfolio.
- CrazyGames — Play free online games at CrazyGames, the best place to play high-quality browser games. We add new games every day. Have fun!
- Recharge — The leading one-stop-shop for all branded payment needs.
Syndicate One helps Belgian startups scale up their businesses through early-stage financing, relevant advice and mentorship.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, SaaS
- Stage:Pre-Seed, Seed, Series A
- Geography: Belgium, United Kingdom, United States
Investor stats
- Total investments: 26
- Round size: Seed $1.4M–$13M; Pre-Seed $1M–$3.3M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $4.8M in 2024
Portfolio highlights
- CrypDefi — Unified custody and compliance for institutional digital finance.
- Donna — Meet Donna, the AI assistant built for field sales teams. Save time, cut admin, and close more deals with less effort.
- Jurimesh — Jurimesh is an AI-powered legal due diligence automation and analyzer workspace using the various tools.
V-Bio Ventures is an independent venture capital firm specialized in building and financing young, innovative life science companies. The fund invests throughout Europe in start-up and early-stage companies with high growth potential focusing on technologies that provide transformational improvements in the biotech, pharmaceutical and agriculturalsectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: Belgium, France, United States
Investor stats
- Total investments: 38
- Round size: Seed $3.2M–$50M; Series A $6.6M–$73M; Series B $20M–$88M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $129M in 2021
Portfolio highlights
- Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
- Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
- Corteria Pharmaceuticals — Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.
KBC Private Equity - the investment company of KBC Group - provides development capital and finances buy-outs to medium-sized companies in Belgium and in Central and Eastern Europe, KBC's home markets.Boasting an experienced team of 28 people, it has more than 60 active investments in portfolio with a market value in excess of EUR 400million.KBC Private Equity aims to become one of the leading private equity providers on KBC Group's home markets. As an active shareholder with a long-term perspective, KBC Private Equity is involved in taking strategic decisions and providing support to management teams.
Show more...Investment focus
- Industry: Biotechnology, Health Care, FinTech
- Stage:Seed, Series A, Series B
- Geography: Belgium, United States, France
Investor stats
- Total investments: 29
- Round size: Seed $549k–$13M; Series A $2.9M–$65M; Series B $33M–$44M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- ELIS — Elis is a multi-services group in Europe and Brazil, specialized in the rental and maintenance of professional clothing and textile articles, as well as hygiene appliance and well-being services. With more than 19,000 employees spread across 13 countries, Elis consolidated turnover in 2014 was €1.331 billion and consolidated EBITDA reached €429million. Benefiting from more than a century of experience, Elis today services more than 240 000 businesses of all sizes in the hotel, catering, healthcare, industry, retail and services sectors, thanks to its network of nearly 300 production and distribution centers and 13 clean rooms, which guarantees it an unrivalled proximity to its clients.
- Rookoo — Rookoo is an AI-driven venue management software that talks to your customers, handles the intake, checks availability, fills your CRM or booking software, and hands off to your team for seamless follow-up.
- ClimateCamp — Looking for a sustainable way to collaborate with your suppliers on emissions reduction projects? Look no further than our platform - Book a demo for free!
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The Faktory is a hub for business ideas based on any disruptive technology with a high potential in international niche markets: ICT, Health, Environment, Media, Broadcast and more.
Show more...Investment focus
- Industry: Software, Analytics, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Belgium, France, United States
Investor stats
- Total investments: 21
- Round size: Seed $1.1M–$4.4M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- IVEX — IVEX offers Repeatable and Scalable Testing & Validation Data Analytics solutions for ADAS/AD Vehicles.
- xyzt.ai — xyzt.ai is a SaaS platform for ANALYTICS, REPORTING and VISUALIZATION of big location data in the Maritime & Ports, Smart City and Logistics industries. EASY & EFFORTLESS
- MyCellHub — MyCellHub.com is a pre-startup from the KULeuven in the biotherapeutics industry that aspires to reform the way cell production processes are organised. With a regulatory compliant Saas-platform for data management and analytics, we increase the efficiency of your manufacturing processes, provide actionable insights via cell culture specificprocess analytics and facilitate regulatory compliance by means of a real-time audit trail and automated batch records.
Early stage Entrepreneurs Coaching and FinancingOne of Europe's leading Business Angels Networks. We connect innovative growth companies to equity finance and coaching by experienced angel investors. The network is 250 members strong and has been assisting innovative entrepreneurs to find financing for more than 10 millions Euros in thelast 4 years.
Show more...Investment focus
- Industry: SaaS, Software, Health Care
- Stage:Seed, Pre-Seed
- Geography: Belgium, France, Spain
Investor stats
- Total investments: 22
- Round size: Seed $247k–$1.5M; Pre-Seed $78k–$373k
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- DeftHedge — DeftHedge is an application addressed to business leaders, and CFOs facing volatility of foreign exchange market.
- NIUM — NIUM is a startup focused on personalized nutrition and gut microbiome research. NIUM created science-based solutions to transform nutrition research and product development.
- TalentGuide — Unlock workforce potential with Talentguide's skills intelligence platform, transforming ambition into measurable ability through actionable insights and personalized development paths.
Expanding nanotechnology into business.
Show more...Investment focus
- Industry: Semiconductor, Manufacturing, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Belgium, United States, Germany
Investor stats
- Total investments: 46
- Round size: Seed $3.3M–$21M; Series A $8.7M–$56M; Series B $12M–$100M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely still investing — raised $351M in 2024
Portfolio highlights
- Spectricity — Spectricity provides multispectral imaging solutions to enhance color accuracy and analysis capabilities in mobile and consumer electronics.
- Onera Health — Introduction to Onera sleep diagnostics and monitoring solutions
- Swave Photonics — Swave develops Spatial Computing, Holography, holographic chips, and holograms in the HXR chip to create 3D augmented and virtual reality and HUD Heads Up Displays
Vives is an interregional seed and early stage technology multi-sector fund. The new fund, initiated by UCLouvain, is a unique European inter-university fund having access to world class innovations from leading EU top universities.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Belgium, France, United States
Investor stats
- Total investments: 25
- Round size: Series A $491k–$46M; Series B $4.4M–$125M
- Lead/follow: 4% lead, 96% follow
- Last fund: May invest from a new fund soon — raised $37M in 2020
Portfolio highlights
- Sunrise — Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Syndesi Therapeutics — Science that Builds Connections
Chemical, Advanced Materials, Cosmetics, Recycling, CleanTech, Plastics and Rubber Manufacturing, Nanotechnology, Biosciences
Show more...Investment focus
- Industry: Health Care, Manufacturing, Information Technology
- Stage:Seed, Series A
- Geography: Belgium, France, Luxembourg
Investor stats
- Total investments: 30
- Round size: Seed $329k–$5.8M; Series A $2.2M–$5.7M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Aerosint — Aerosint invented a technology called "Selective Powder Deposition" which deposits multiple powders in each layer. This unlocks multi-material 3D printing.
- Daphne Technology — Measure and abate methane slip with Daphne Technology. Learn how we reduce emissions in gas engine exhaust. Contact us today!
- Zeopore Technologies — Zeopore Technologies innovates zeolite mesoporization to optimize catalysts that enhance processes in refining and petrochemical industries. This leads to higher quality products, lower energy use and less waste, using an approach that is affordable, easily scalable and non-hazardous.
Ark Angels Activator Fund SA is a closed venture capital fund (closed-end private equity investment fund) with a capital of 14.8 M EUR. The Fund is recognized as ARKIV and has obtained the status of Private Privak under Belgian law. The Fund is managed by a management company set up by BAN Vlaanderen VZW, ING Belgium & the two fund managers.The Fund initially acted primarily as a co-investor in investments made by business angels who are members of BAN Vlaanderen, but then also co-invested with other capital providers. It focuses not only on investments in young growth companies, but also on companies in the growth or transfer phase with an operating office in Flanders,
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Series A, Seed
- Geography: Belgium
Investor stats
- Total investments: 20
- Round size: Seed $932k–$1.6M; Series A $1.2M–$7.4M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Apicbase — Apicbase is a F&B management platform that gives you total visibility of your back of house so you can grow without compromise.
- waylay — Waylay is a leading Enterprise IT-OT digital unification software company delivering low-code based orchestration, automation and analytics software solutions. Waylay has a passion for supporting enterprises on their IoT automation journey and ensuring it puts all valuable data to work for developers, data scientists and domain experts.
- Accelleran — Accelleran is pioneering a disruptive approach to the delivery of cost-effective, carrier and mission-critical grade TDD and FDD Small Cell networks through its focus on software quality and partnerships with volume manufacturers.Accelleran provides LTE Small Cell software and LTE Small Cell product solutions which address the real-worldchallenges of volume deployment of Small Cells. We offer turnkey solutions and unique experience on the challenges of integrating cellular technology on low cost, yet powerful platforms and architectures. Accelleran offers its customers solid and dependable system solutions, backed by the support of our unparalleled expertise.Accelleran’s technology is genuinely independent from any HW platform and enables operators to invest once in the integration and validation of a common software base that can be deployed across different segments, platforms and Small Cell architectural approaches to enable a truly integrated HetNet.
Regional Investment Company of Brussels
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Seed, Series A
- Geography: Belgium, France
Investor stats
- Total investments: 19
- Round size: Seed $1.5M–$5.5M; Series A $2.3M–$4.2M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Fyteko — For a more sustainable agriculture
- AI-Blox — A modular & flexible hardware and software platform for edge AI applications.
- AnyKrowd — Anykrowd specializes in providing an all-in-one cashless payments and ticketing solution aimed at enhancing event experiences. The company focuses on increasing revenue for event organizers while reducing operational costs. Anykrowd's platform is designed to support the creation of various ticket types, including early bird, multiple days, andVIP tickets, catering to the diverse needs of events. With a commitment to technological innovation, Anykrowd continuously develops new tools to stay aligned with the evolving demands of the event industry. The company also emphasizes sustainability and the future of event management by offering easy-to-use event technology and management tools.
Strategic research in on life sciences and biotechnology
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: Belgium, Brazil, Denmark
Investor stats
- Total investments: 21
- Round size: Seed $3.2M–$4.6M; Series A $6.8M–$84M; Series B $4.4M–$65M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Biotalys — Biotalys is an Agricultural Technology (AgTech) company that employs its proprietary Agrobody technology platform to develop crop and food protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combinethe high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications.It was incorporated in 2013 and is based in the Biotech hub in Ghent, Belgium.
- Confo Therapeutics — Confo Therapeutics is a clinical-stage company committed to accelerating novel GPCR-directed medicines for metabolic & endocrine diseases.
- Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
Basic and applied research fund of the Flemish regional government in Belgium
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Grant, Pre-Seed, Seed
- Geography: Belgium, Israel, Germany
Investor stats
- Total investments: 36
- Round size: Seed $517k–$1.9M; Grant $261k–$3.2M; Pre-Seed $200k–$2M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- WeHave — Enter the cookieless era of advertising with WeHave's first-party data collaboration. Leverage external data in a gdpr compliant way.
- Summ.link — Summ.link works to transform enterprises by enhancing the employee experience through strategy and strong insights based on trustworthy data, which leads to improvements in digital processes. By putting a strong emphasis on data intelligence and people analytics, it seeks to provide everyone in the organization with actionable information.Application development, big data, AI, cloud solutions, and other services are among their offerings.
- Gorilla — We empower Energy Retailers in pricing, forecasting and reporting with data-driven solutions in boosting speed and flexibility.
Angelwise Vlaams Investeringsfonds
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Belgium, The Netherlands
Investor stats
- Total investments: 14
- Round size: Seed $521k–$3M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- xyzt.ai — xyzt.ai is a SaaS platform for ANALYTICS, REPORTING and VISUALIZATION of big location data in the Maritime & Ports, Smart City and Logistics industries. EASY & EFFORTLESS
- Watcherr — This is the homepage of the website
- Sealution — Sealution is a startup that was founded to improve connectivity on board of merchant vessels to enable IoT solutions.For decades, the maritime sector has been lagging behind in terms of digital innovation due to the impenetrable steel walls below deck that made it impossible for any signal to get to the bridge.At Sealution we are bringing thesector into the 21st century.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Ontdek een bank-verzekeraar dicht bij u: rekeningen, kaarten, kredieten, sparen en verzekeringen. Beheer alles online of in kantoor, volgens uw behoeften.
Show more...Investment focus
- Industry: Software, SaaS, Pharmaceutical
- Stage:Debt Financing, Seed, Pre-Seed
- Geography: Belgium, France, The Netherlands
Investor stats
- Total investments: 19
- Round size: Seed $291k–$1.1M; Pre-Seed $291k–$1.4M; Debt Financing $1.1M–$382M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Alan — Alan provides online digital insurance services focusing on health and wellness. The company offers health insurance services, providing solutions tailored to the needs of different types of businesses. It provides simple and seamless insurance coverage and easy claim handling. It gives access to medical professionals for users to easily andconveniently get medical advice and manage claims and reimbursements.
- Hexa — eFounders partners with talented co-founders to build the future of product-led SaaS.
- Storm — Storm focuses on wind energy solutions, developing and managing wind farms for renewable energy production.
We empower high-potential entrepreneurship and democratize venture capital. Discover promising start-ups & SMEs and invest alongside business angels.
Show more...Investment focus
- Industry: E-Commerce, Health Care, Online Portals
- Stage:Series A, Seed, Series B
- Geography: Belgium, France
Investor stats
- Total investments: 14
- Round size: Seed $165k–$1.3M; Series A $247k–$2.5M; Series B $165k–$680k
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Opinum — What is Opinum Data Hub? Our Data Hub is a secured Cloud-based platform that allows energy and environmental actors to centralise, enhance, analyse, and share data.
- Digiteal — Digiteal offers a wide range of services for e-invoice presentment, electronic payments and open banking.
- NietsCo — NietsCo. is the home of Botaniets Gin 0.0%, a leading selection of alcohol-free products, carefully distributed to the world's best restaurants, concept stores, shops and consumers.
XAnge is a Franco-German team of venture capital investors that manages €450 million and invests in digital, deeptech, and impact startups.It is the innovation brand of the Siparex group, a major player in French private equity. XAnge is a key European investor in early-stage startups and is looking for game-changing startups and entrepreneurswho rock the code[s].The Paris, Ile-de-France-located company was founded in 2004.
Show more...Investment focus
- Industry: Software, SaaS, E-Commerce
- Stage:Series A, Seed, Series B
- Geography: France, Germany, Belgium
Investor stats
- Total investments: 210
- Round size: Seed $1.1M–$8M; Series A $3M–$22M; Series B $6M–$60M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $234M in 2021
Portfolio highlights
- Tomorro — Leeway helps you reduce the time spent on contract management and gives you more control and visibility over legal and financial risks.
- Request Finance — A suite of financial tools to make your life easier - crypto organizations & freelancers use Request for invoices, expenses, payroll or accounting.
- POLLEN Metrology — The revolution of artificial intelligence for high performance materials. Accelerate the time to yield of new materials and processes.
Newion is a venture capital firm focused on early-stage investments in B2B software companies. Its mission is to support entrepreneurs in building software companies into category leaders that create sustainable impact, and in doing so generate excellent returns to its investors.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Series A, Seed
- Geography: The Netherlands, Belgium, Germany
Investor stats
- Total investments: 75
- Round size: Seed $796k–$6.6M; Series A $1.1M–$7.4M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — raised $148M in 2022
Portfolio highlights
- NjiaPay — Payments-as-a-Service platform that will streamline your operations and elevate your online payments across the African continent.
- nuwacom — AI that understands your business - nuwacom turns your knowledge into content, collaboration, and automated workflows that scale.
- Dexter Energy Services — Dexter helps asset-backed renewable traders maximize profits through accurate forecasts and price insights, day-ahead to real time.
The CoFoundry helps entrepreneurs transform their ideas into sustainable companies. Some say we cut through the funding hype and work hard to give your business a sustainable future.
Show more...Investment focus
- Industry: Software, SaaS, Security
- Stage:Seed, Series A
- Geography: Belgium, The Netherlands, United States
Investor stats
- Total investments: 14
- Round size: Series A $878k–$3.9M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Aloxy — Aloxy offers reliable IIot solutions tailored to the needs of the process industry. Our valve sensor provides an open and close indication of manual valves.
- MyCellHub — MyCellHub.com is a pre-startup from the KULeuven in the biotherapeutics industry that aspires to reform the way cell production processes are organised. With a regulatory compliant Saas-platform for data management and analytics, we increase the efficiency of your manufacturing processes, provide actionable insights via cell culture specificprocess analytics and facilitate regulatory compliance by means of a real-time audit trail and automated batch records.
- Vaultspeed — Save your teams months of headache with a no-code approach to automate your multi-source data integration, Data Vault modeling & ETL/DDL code generation.
Startups, increase your value by 3 within 9 months thanks to Power 3 by Leanfund (www.leanfund.com)!
Show more...Investment focus
- Industry: Internet, Apps, Software
- Stage:Seed, Series B
- Geography: Belgium, United States, France
Investor stats
- Total investments: 12
- Round size: Seed $66k–$384k
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- Neveo — With one click, send photos and messages on a family newspaper that your senior will receive every month.
- Supersec — Good to eat, good to think: discover the Supersec organic, healthy, artisanal and sustainable food treats available in bulk delivery!
- Sortlist — Discover the most relevant agencies for your project based on your own specific requirements.
Our mission is to mature innovation and support the growth of our portfolio companies to create value for patients, society, local ecosystems, and investors.
Show more...Investment focus
- Industry: Biotechnology, Medical, Pharmaceutical
- Stage:Series A, Seed
- Geography: Belgium, Japan, France
Investor stats
- Total investments: 20
- Round size: Seed $2.7M–$3.2M; Series A $5.9M–$84M
- Lead/follow: 65% lead, 35% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- AdipoPharma — AdipoPharma SAS is dedicated to learning more about the role of adipocyte cells in diabetes. AdipoPharma is using the adipocyte's power to treat insulin resistance, type 2 diabetes, and other diseases.
- Tensegrity Pharma — Tensegrity Pharma is the developer of a novel drug designed to minimize bottlenecks and provide innovative value to patients.
- Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
European early-stage venture capital fund backed 100% by founders. Helping Pre-Seed and Seed SaaS, Marketplaces & Platforms with their Go-To-Market.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Pre-Seed
- Geography: The Netherlands, Germany, Sweden
Investor stats
- Total investments: 101
- Round size: Seed $550k–$5M; Pre-Seed $549k–$2.6M
- Lead/follow: 61% lead, 39% follow
Portfolio highlights
- Stack — Stack is an immersive experience of the internet with collaboration at its core. Achieve more with your peers in an organized environment
- Basalt — Basalt is an end-to-end AI reliability platform designed to help teams build, test, deploy, and monitor AI agents.
- Sonomo — Invest in music royalties and earn monthly dividends. Thousands of assets to trade from and build a balanced portfolio. Start today.
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Belgium, Germany, France
Investor stats
- Total investments: 59
- Round size: Series A $3.8M–$20M; Series B $4.4M–$27M; Series C $6.9M–$100M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
- ENYO Pharma — ENYO Pharma is a biopharmaceutical company incorporated in Jan, 2014, by four scientists of the Infectiology Research Center in Lyon, France, and three seeding partners (2 privates and 1 public).The company is based in the Infectiology Center of Lyonbiopôle in Lyon, France and maintains tight collaborations with the seminal Inserm team and theBSL4 laboratory Inserm-Jean Mérieux.ENYO Pharma has licensed several Inserm patents issued from the discoveries of the founding scientists and developed a unique platform for the identification of intracellular therapeutic targets and molecules.The company is developing treatments against the most important viruses and is thriving to become a global leader in anti-virals. Research and Development is currently focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company plans to conduct its molecules to Phase II clinical trials.
- Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
Supporting Exceptional entrepreneurs. We value emotional intelligence as much as data, growing internal culture as much as growing revenue, and forming strong, personal bonds with founders. We recognize patterns where other don't.
Show more...Investment focus
- Industry: Software, Cloud Computing, Apps
- Stage:Series A, Series B
- Geography: Belgium, The Netherlands, United States
Investor stats
- Total investments: 19
- Round size: Series A $1M–$2.7M; Series B $6M–$9M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Amplidata — From high-performance ingest that powers AI applications and demanding data-intensive workloads, to massive, durable data lakes to fuel AI models, Quantum offers the most comprehensive and cost-efficient data management solutions.
- Clear2Pay — Clear2Pay is an innovative payments technology company focused on delivering globally applicable solutions for secure, timely and streamlined payments processing. Clear2Pay's Open Payment Framework (OPF) enables financial institutions to improve internal payments processing efficiencies whilst at the same time providing their clients withbetter payment services that are faster, with richer payments related information.Clear2Pay's solutions within the Service- Oriented Architecture (SOA) based Open Payment Framework offer financial institutions the ability to process payments through a centralised payments engine that utilises a library of re-useable business services across all payment types. The bank can thus combine new services models with existing infrastructures, thereby protecting previous investments whilst gradually moving to a more modern efficient payments environment.
- Racktivity — Racktivity, an innovator in next-generation power, energy and environmental management solutions offers the industry's only integrated hardware and software for critical infrastructures.The DCPM suite, a Service Provider Infrastructure & Data Center Performance Management System, measures, monitors and manages power across distributeddata centres and gives customers full visibility and control of their energy consumption while integrating seamlessly with other applications and PDU appliances.Racktivity's EnergySwitch family of smart Power Distribution Units (PDUs), and sensors equips infrastructures with the most advanced metering, switching and predictive analysis capabilities available on the market today.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!TheClubDeal is an investment holding and fund manager co-investing into SME’s and real estate projects. It provides facilitation of governance between non-executive shareholders and entrepreneurs. Its governance structure, including its charter of avoidance of conflict of interests, is therefore paramount to the adequate management of the Company.At TheClubDeal, we connect Investors and Entrepreneurs around promising investment opportunities. For each of these, we will invest ourselves and co-invest with a selected number of investors. We add value by processing strong applied governance principles, when selecting and managing our investments, and by gathering the necessary skills to successfully grow the businesses and real-estate projects we co-invest in. TheClubDeal is launching their second fund, a 50M € PRIVAK/PRICAF in H1 2021 with the mandate to invest in Belgian scale-ups in three sectors: Smart Living, Tech and Life Sciences.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Information Technology
- Stage:Series A, Series B, Seed
- Geography: Belgium, France
Investor stats
- Total investments: 17
- Round size: Series A $2.2M–$7.7M; Series B $12M–$18M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
- Inpulse — Inpulse is an automated supply management platform for restaurateurs.
- Clouds of care — Increasing your probability of success through the adoption of meaningful endpoints, starting from electrophysiology.
Find out if E-Merge is the right fit for your future career! Explore jobs, salary, equity, and funding information. Read about work-life balance, perks, benefits, and the company culture!
Show more...Investment focus
- Industry: Software, SaaS, E-Commerce
- Stage:Seed, Series A
- Geography: United States, Belgium, Spain
Investor stats
- Total investments: 69
- Round size: Seed $213k–$3.5M; Series A $700k–$25M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — raised $267k in 2019
Portfolio highlights
- Invopop — Issue compliant invoices, globally
- Work Today — Create one profile. Apply to thousands of jobs in minutes.
- Anagram — Anagram is making vision care more affordable and accessible for providers and consumers. Thousands of eye care practices use Anagram to operate independently, process out-of-network benefits, and deliver better pricing on eyewear for their patients.
Corporate site of ING, a global financial institution of Dutch origin, providing news, investor relations and general information
Show more...Investment focus
- Industry: Energy, Renewable Energy, Solar
- Stage:Debt Financing, Post-IPO Debt
- Geography: United Kingdom, United States, The Netherlands
Investor stats
- Total investments: 95
- Round size: Post-IPO Debt $116M–$3B; Debt Financing $75M–$1.6B
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Terra-Gen — Terra-Gen was established in August 2007, led by an experienced executive management team averaging over 25 years of relevant industry experience. The team has contracted or re-contracted over 10,000 MW of power generation facilities and has developed or acquired over $25 billion in assets over their careers.
- Akaysha Energy — Discover innovative and sustainable renewable energy solutions with Akaysha Energy. Powering Australia's future with clean, reliable energy.
- Glenveagh Properties — Glenveagh Properties PLC, formerly Glenveagh Properties Ltd, is an Ireland-based company focused on developing and building starter, mid-size and executive and high-end homes, with a principal focus on the Greater Dublin Area, either for itself or on behalf of third parties. Its flagship residential development site is the Marina village, which islocated beside the marina in Greystones with clear views of the Irish Sea to the east and the Wicklow Mountains to the west. Its other developments include Cois Glaisin, Co. Meath that focuses on first-time buyer homes and is located in the Dublin commuter-belt town of Navan,; Holsteiner Park, Clonee that is a development of 15 detached houses built on half acre plots; Milltown Meadows that is located in Ashbourne and comprises 67 homes; and Herbert Hill that comprises apartments and is located in the centre of Dundrum.
Theodorus is the spin-off fund of Université Libre de Bruxelles that invests ininvest in early stage projects based on proprietary disruptive technologies.
Show more...Investment focus
- Industry: Health Care, Life Science, Medical
- Stage:Seed, Series A
- Geography: Belgium, Canada, France
Investor stats
- Total investments: 13
- Round size: Seed $3.7M–$11M; Series A $2.2M–$6.6M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- DrugBank — DrugBank augments human intelligence to improve the world’s health. Our suite of products are powered by the world’s most complete and up-to-date pharmaceutical knowledge database. It includes everything there is to know about drugs and how they work in the body. We enable companies to improve healthcare delivery through precision medicine orclinical software applications, as well as uncover insights through data science in drug discovery. Our knowledge base can be integrated into software solutions to help achieve clinical intelligence. Companies can easily scale their usage through our API and launch faster with flexible data modules. By providing users with advanced insights and the right information at the right time, users are empowered to make better health decisions.Our extensive, structured datasets are used to discover novel drug candidates, identify drug repurposing opportunities, and build predictive machine learning models. Companies working with data science can find answers quickly and get drugs to market faster with our evidence-based drug information. Lastly, our publicly available resource, DrugBank Online, is free-to-use with limited datasets available for download for academic and non-commercial researchers. DrugBank has been cited in over 13,000 academic publications and is used by millions of researchers and health professionals globally.
- HYPNO VR — HypnoVR is a virtual reality software for anesthesia, treatment of pain, and anxiety. It was founded in 2016 and is based in Strasbourg, France.
- Cascador Health — Cascador Health bridges the gap between sources and users of healthcare data. Using curated, validated and anonymized RWD allows healthcare providers and life science industry to gain insights and provide better care.
SFPIM investment firm that invests in technology and infrastructure.
Show more...Investment focus
- Industry: Biotechnology, AgTech, Agriculture
- Stage:Series A, Series B, Series C
- Geography: Belgium, France
Investor stats
- Total investments: 11
- Round size: Series A $8.8M–$110M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Fyteko — For a more sustainable agriculture
- Biotalys — Biotalys is an Agricultural Technology (AgTech) company that employs its proprietary Agrobody technology platform to develop crop and food protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combinethe high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications.It was incorporated in 2013 and is based in the Biotech hub in Ghent, Belgium.
- Swave Photonics — Swave develops Spatial Computing, Holography, holographic chips, and holograms in the HXR chip to create 3D augmented and virtual reality and HUD Heads Up Displays
Finindus provides early stage financing and growth capital to innovative companies active in the area of materials, material processing and sustainable manufacturing. We are funded by ArcelorMittal and the Flemish Region and linked to OCAS, the world class metals research center located in Belgium.
Show more...Investment focus
- Industry: Manufacturing, Industrial, Renewable Energy
- Stage:Series A, Seed
- Geography: Belgium, United States, Sweden
Investor stats
- Total investments: 29
- Round size: Seed $1.3M–$5.5M; Series A $3.5M–$18M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- OTIV — OTIV offers autonomous technology to make your railway operations in complex environment safer and more efficient.
- Ventory — Ventory is an affordable, intuitive, and easy-to-use platform that gives field professionals full visibility and real-time control over remote inventory.
- Fortius Metals — Fortius Metals is an innovative metal 3D printing company. Fortius Metals provides patented high performance wire consumables for advanced manufacturing including welding, joining and 3D printing
Entourage is a venture Studio and early stage VC that invests in early-stage B2B and SaaS sectors.
Show more...Investment focus
- Industry: B2B, Analytics
- Stage:Seed
- Geography: Belgium
Investor stats
- Total investments: 9
- Lead/follow: no public data
Portfolio highlights
- Dealcar — DEALCAR is a company that digitalizes the used car market through a SaaS platform, enabling fully digital transactions. This platform creates a network effect benefiting dealers, partners, and customers. • Dealers: Increase revenue by selling extra products and boost sales by reducing turnover time. • Partners: Distribute products at the pointof sale without marketing expenses, lowering operational costs. • Consumers: Purchase a used car easily in just three steps, enjoying a smooth, trusted process similar to renting but with the benefits of owning a car.
- Karomia — Karomia is an efficient and engaging B2B SaaS solution supporting sustainability officers in conducting a Double Materiality Assessment (DMA) of their organization, as part of their ESG report.
- Warren — Enabling wealth, Boosting welfare
Spinventure supports the creation of spin-off companies that aim to industrialize and commercialize the result of scientific research. Spinventure was born from a collaboration between MEUSINVEST and the University of Liège. It is headquartered in Angleur, Belgium.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A
- Geography: Belgium
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Dim3 — Improve patients outcome - Deliver actionable insights - Save healthcare costs
- Elysia — Elysia developed solution dedicated to quality control laboratories for the production of Radio Pharmaceuticals.
- Convert Pharmaceuticals — Convert Pharmaceuticals develops prodrugs that are inert upon administration to patients, but transform into potent anti-cancer agents upon entering tumors.
Saffelberg Investments is an independent investment company with a 250 million EUR capital base. We focus on long term investments by taking both majority stakes and substantial minorities in fast-growing ventures through risk-bearing capital.
Show more...Investment focus
- Industry: Software, Fashion, E-Commerce
- Stage:Series A, Seed
- Geography: Belgium
Investor stats
- Total investments: 7
- Round size: Series A $2.7M–$4.4M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- BRIKL — Brikl is the world's leading e-Commerce MicroStore technology. Build team stores, club shops, and custom products using our 3D configurator.
- Radian Arc — Radian Arc is a content delivery network (CDN) that sets up broadband services around the world to make it easier to send video or gaming data to consumers.
- Tangent Works — Create predictive models in seconds for faster and better forecasting & anomaly detection with TIM InstantML.
Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, The Netherlands, Switzerland
Investor stats
- Total investments: 168
- Round size: Series A $6.9M–$77M; Series B $8.6M–$103M; Series C $12M–$140M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $266M in 2023
Portfolio highlights
- Neuravi — Neuravi is an early stage company in the large emerging neurointerventional device market. Led by a team experienced in endovascular device development and global commercialization, the company's initial technology platform addresses acute ischemic stroke. In collaboration with international researchers and clinicians, the company seeks todevelop new understanding that will drive innovative solutions to treat this challenging and devastating disease. Neuravi was founded in 2009 and is headquartered in Galway, Ireland, home to many of the world’s leading medical device companies.
- Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
- Mosanna Therapeutics — Mosanna is a Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach.
VC funding in Belgium at a glance
Stats across 1.4k deals from 986 investors.
Access all 986 VC funds in Belgium startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the VC Funds in Belgium investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 986 VC funds investing in Belgium startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!